Prevention of mother to child transmission of HIV: Evaluation of a pilot programme in a district hospital in rural Zimbabwe

British Medical Journal

Volumn 329, Issue 7475, 2004, Pages 1147-1150

  Perez, Freddy ^a   Orne Gliemann, Joanna ^a   Mukotekwa, Tarisai ^b   Miller, Anna ^c   Glenshaw, Monica ^d   Mahomva, Agnes ^e   Dabis, François ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b ISPED Zimbabwe Programme   (Zimbabwe)

^c E Glaser Paediatr AIDS Found   (Zimbabwe)

^d Min Hlth/Child Welf Zimbabwe   (Zimbabwe)

^e PMTCT Unit   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE;

ADULT; EVALUATION; FEMALE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NURSING STAFF; PATIENT COUNSELING; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; SOCIAL WORKER; VIRUS TRANSMISSION; ZIMBABWE;

EID: 8744315599     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.329.7475.1147     Document Type: Review

References (23)

1. United Nations Joint Program on HIV/AIDS (UNAIDS). Report on the global HIV/AIDS epidemic, December 2003. Geneva: UNAIDS, 2003.
2. Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet 2002;359:2097-104.
3. Ministry of Health and Child Welfare, Zimbabwe. Zimbabwe national HIV and AIDS estimates 2003. Harare: Ministry of Health, 2003.
4. Ministry of Health and Child Welfare, Zimbabwe. Report of the consultation of provincial medical directorates on initiating and scaling-up prevention of mother-to-child transmission of HIV infection in Zimbabwe-Gweru 15-16 May 2001. Harare: MTCT Unit, AIDS and TB Programme, 2001.
5. Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999;353:786-92.
6. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 2003;362:859-68.
7. The Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002;359:1178-86.
8. Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 2003;187:725-35.
9. Ministry of Health and Child Welfare, Zimbabwe. National action plan for use of nevirapine to reduce mother-to-child HIV transmission in operational research settings in Zimbabwe. (First draft, May 2001.) Harare: MTCT Unit, AIDS and TB Programme, 2001.
10. Gregson S, Chandiwana SK. The Manicaland HIV/STD prevention project: studies on HIV transmission, impact and control in rural Zimbabwe. Zimbabwe Science News 2001;35:27-42
11. World Health Organization. The health sector response to HIV/AIDS: coverage of selected services in 2001-preliminary assessment, 2002. Geneva: WHO, 2001.
12. Stringer EM, Sinkala M, Stringer JS, Mzyece E, Makuka I, Goldenberg RL, et al. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS 2003;17:1377-82.
13. Temmerman M, Quaghebeur A, Mwanyumba F, Mandaliya K. Mother-to-child HIV transmission in resource poor settings: how to improve coverage? AIDS 2003;17:1239-42.
14. Msellati P, Hingst G, Kaba F, Viho I, Welffens-Ekra C, Dabis F. Operational issues in preventing mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire, 1998-99. Bull World Health Organ 2001;79:641-7.
15. Songok E, Fujiyama Y, Tukei P, Vulule J, Kiptoo M, Adungo N, et al. The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya. Am J Trop Med Hyg 2003;69:8-13.
16. Perez-Then E, Pena R, Tavarez-Rojas M, Pena C, Quinonez S, Butler M, et al. Preventing mother-to-child transmission in a developing country: the Dominican Republic experience. J Acquir Immune Defic Syndr 2003;34:506-11.
17. Ministry of Health and Child Welfare, Zimbabwe. The prevention of mother to child transmission of HIV programme, 2002 annual report. Harare: National AIDS and Tuberculosis Programme, 2003.
18. Stringer J, Rouse D, Sinkala M, Marseille E, Vermund S, Stringer E, et al. Nervirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus. Lancet 2003;362:1850-53.
19. Saman M, Kruy LS, Glaziou P, Rekacewicz C, Leng C, Min DC, et al. Feasibility of antenatal and late HIV testing in pregnant women in Phnom Penh Cambodia: the PERIKAM/ANRS1205 study. AIDS 2002;16:950-1.
20. World Health Organization. Antiretroviral drugs and the prevention of mother-to-child transmission of HIV infection in resource-limited settings. Expert consultation, Geneva, 5-6 February 2004: a summary of main points from the meeting. www.who.int/3by5/arv_pmtct/en (accessed 22 Mar 2004).
21. Mitka M. MTCT-Plus programme has two goals: end maternal HIV transmission + treat mothers. JAMA 2002;288:153-4.
22. World Health Organization, Division of Diarrhoeal and Acute Respiratory Disease Control. Integrated management of the sick child. Bull World Health Organ 1995;73:735-40.
23. Horwood C, Liebeschuetz S, Blaauw D, Cassol S, Qazi S. Diagnosis of paediatric HIV infection in a primary health care setting with a clinical algorithm. Bull World Health Organ 2003;81:858-66.